Maren Høland recently received the degree of Master of Science by the University of Oslo, Institute for Molecular Biosciences. In her masters project Maren investigated in situ expression of 11 different protein markers and their prognostic value in malignant peripheral nerve sheath tumors. The main findings were the identification of two different immunohistochemical protein expression profiles that could distinguish a high risk patient group from a low risk group, even among patients in complete remission.
The M.Sc. project was supervised by Dr. Matthias Kolberg and Prof Ragnhild A. Lothe (co-supervisor).
Maren has recently received a PhD grant from the Institute of Clinical Medicine, University of Oslo, and will work in the Lothe group at the Centre for Cancer Biomedicine.
Pharo H, Brandt-Winge S, Thorkildsen EM, Vedeld HM, Lind GE(2026) DNA Methylation Analyses of Tissue Samples and Cell-Free DNA by Droplet Digital PCR Methods Mol Biol, 2969, 179-193 DOI 10.1007/978-1-0716-4767-7_12, PubMed 41073866
Kuzu OF, Granerud LJT, Saatcioglu F(2025) Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations Signal Transduct Target Ther, 10(1), 358 DOI 10.1038/s41392-025-02439-w, PubMed 41130962
Osterlund E, Ristimäki A, Nunes L, Kytölä S, Aho S, Heervä E, Uutela A, Lehtomäki K, Stedt H, Halonen P, Kontiainen J, Muhonen T, Kallio R, Sundström J, Ålgars A, Ristamäki R, Nieminen L, Sorbye H, Pfeiffer P, Salminen T, Nordin A, Lamminmäki A, Mäkinen MJ, Sjöblom T, Isoniemi Het al.(2025) KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts BJC Rep, 3(1), 72 DOI 10.1038/s44276-025-00188-5, PubMed 41120702